| scholarly article | Q13442814 |
| P50 | author | Tom Fahey | Q28359600 |
| Peter H. Whincup | Q37390434 | ||
| Fiona C Lampe | Q62006742 | ||
| Shah Ebrahim | Q90615321 | ||
| P2093 | author name string | Jonathan Emberson | |
| Mary Walker | |||
| Peter Brindle | |||
| P2860 | cites work | Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials | Q28343811 | ||
| A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study | Q30713072 | ||
| Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33740111 | ||
| Updated New Zealand cardiovascular disease risk-benefit prediction guide | Q33800200 | ||
| Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations | Q33854955 | ||
| Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias | Q34037840 | ||
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
| British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns | Q34782600 | ||
| Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men | Q35370250 | ||
| Prevalence of ischaemic heart disease in middle aged British men. | Q36750075 | ||
| Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality | Q36750680 | ||
| Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators | Q36860419 | ||
| Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population | Q37315239 | ||
| Using the Framingham model to predict heart disease in the United Kingdom: retrospective study | Q37315567 | ||
| Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 | ||
| Accuracy of death certificates for coding coronary heart disease as the cause of death | Q43891160 | ||
| The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community | Q44587445 | ||
| Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts | Q52017724 | ||
| Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. | Q52082107 | ||
| Cardiovascular disease risk profiles. | Q52461317 | ||
| An updated coronary risk profile. A statement for health professionals. | Q52461335 | ||
| Estimation of CHD risk in a French working population using a modified Framingham model | Q56788609 | ||
| Primary prevention of coronary heart disease | Q57264490 | ||
| Twenty year follow-up of a cohort based in general practices in 24 British towns | Q57416376 | ||
| Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association | Q63977549 | ||
| Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) | Q74519754 | ||
| Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention | Q77714696 | ||
| P433 | issue | 7426 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1267 | |
| P577 | publication date | 2003-11-29 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study | |
| P478 | volume | 327 |
| Q52936363 | A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. |
| Q37217516 | A comparison of South Asian specific and established BMI thresholds for determining obesity prevalence in pregnancy and predicting pregnancy complications: findings from the Born in Bradford cohort |
| Q42275051 | A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea. |
| Q33686501 | A simple risk score using routine data for predicting cardiovascular disease in primary care |
| Q38044398 | A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary prevention |
| Q24655103 | Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial |
| Q35772791 | Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review |
| Q45960894 | Accurate prediction of coronary artery disease using reliable diagnosis system. |
| Q96303354 | Age and sex affect deep learning prediction of cardiometabolic risk factors from retinal images |
| Q35776957 | Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites |
| Q35772358 | American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively |
| Q35553113 | An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort |
| Q37272230 | An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study |
| Q35806287 | Analysis of short-term heart rate and diastolic period variability using a refined fuzzy entropy method |
| Q36766993 | Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians |
| Q37606104 | Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study. |
| Q39113028 | Assessment of diet quality improves the classification ability of cardiovascular risk score in predicting future events: The 10-year follow-up of the ATTICA study (2002-2012). |
| Q36643600 | Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date |
| Q30396421 | Associations between Carotid Artery Plaque Score, Carotid Hemodynamics and Coronary Heart Disease |
| Q51767416 | Attitudes to and application of the concept of overall cardiovascular risk: comparison of male and female primary care providers. |
| Q27004493 | Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity |
| Q35905575 | Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study. |
| Q60441707 | Body mass index and mortality: results of a cohort of 184,697 adults in Austria |
| Q35771476 | By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease |
| Q35204388 | COSEHC global vascular risk management quality improvement program: rationale and design |
| Q36142850 | Calibrating parametric subject-specific risk estimation |
| Q37226156 | Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population. |
| Q24657952 | Can non-physician health-care workers assess and manage cardiovascular risk in primary care? |
| Q57235880 | Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades |
| Q34249451 | Cardiology. |
| Q35772030 | Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study. |
| Q45334537 | Cardiovascular disease risk in a semirural community in Malaysia |
| Q37274649 | Cardiovascular risk after bariatric surgery for obesity |
| Q36012817 | Cardiovascular risk assessment and management in developing countries |
| Q48524602 | Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study |
| Q37348704 | Cardiovascular risk assessment scores for people with diabetes: a systematic review |
| Q33586716 | Cardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population |
| Q34683655 | Cardiovascular risk estimation: important but may be inaccurate |
| Q30987054 | Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse [...] |
| Q36768870 | Cardiovascular risk prediction tools for populations in Asia |
| Q43077620 | Cardiovascular risk tables |
| Q36777079 | Carotid IMT is more associated with stroke than risk calculators |
| Q46298305 | Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA study |
| Q26774158 | Chronic Inflammatory Diseases and Endothelial Dysfunction |
| Q92423282 | Clinical, Demographic, and Biochemical Characteristics of Patients with Acute ST-Segment Elevation Myocardial Infarction: An Analysis of Acute Coronary Syndrome Registry Data of a Single Medical Center from 2005 to 2016 |
| Q36704257 | Clues to cardiovascular risk: an office-based approach |
| Q35884178 | Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative |
| Q37672911 | Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score |
| Q34164321 | Coronary Risk Assessment by Point-Based vs. Equation-Based Framingham Models: Significant Implications for Clinical Care |
| Q41172568 | Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals |
| Q36772302 | Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events |
| Q37614187 | Coronary heart disease attributable to passive smoking: CHD Policy Model |
| Q39293278 | Coronary heart disease risk in men and the epidemic of overweight and obesity |
| Q28167348 | Coronary risk scores |
| Q36916048 | Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects |
| Q38236292 | Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK. |
| Q47610370 | Could Bertrand Russell's barber have bitten his own teeth? A problem of logic and definitions |
| Q55496270 | Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus? |
| Q33514099 | Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population |
| Q35902547 | Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. |
| Q49043410 | Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension |
| Q45140959 | Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study |
| Q36817362 | Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study |
| Q45237334 | Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia |
| Q37195360 | Development of Health Parameter Model for Risk Prediction of CVD Using SVM. |
| Q40183409 | Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men. |
| Q33834899 | Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study |
| Q46868484 | Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study |
| Q35097723 | Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. |
| Q36118727 | Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. |
| Q34027133 | Endothelial function as a functional expression of cardiovascular risk factors |
| Q35741878 | Established risk factors account for most of the racial differences in cardiovascular disease mortality |
| Q33944736 | Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study |
| Q28602638 | Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited) |
| Q35786601 | Exercise Effects on Risk of Cardiovascular Disease among Iranian Women |
| Q51645274 | Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population. |
| Q44455102 | Framingham is in Massachusetts |
| Q31139249 | Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe. |
| Q47657268 | Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study |
| Q34299778 | Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. |
| Q33355191 | Healthy hearts--a community-based primary prevention programme to reduce coronary heart disease |
| Q41431612 | High rate of increased carotid intima-media thickness and atherosclerotic plaques in Chinese asymptomatic subjects with central obesity |
| Q38620513 | How close are we to implementing a genetic risk score for coronary heart disease? |
| Q35114182 | Hypertension education and adherence in South Africa: a cost-effectiveness analysis of community health workers |
| Q88128165 | Implication of coronary CT angiography combined with four-dimensional speckle tracking echocardiography for predicting major adverse cardiac events |
| Q34611998 | Improvement in prediction of coronary heart disease risk over conventional risk factors using SNPs identified in genome-wide association studies |
| Q34557332 | In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study |
| Q38624632 | Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry |
| Q37201693 | Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus |
| Q47205338 | Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study |
| Q33684924 | Is clinical decision support the missing link in prevention? Comment on "Shared electronic vascular risk decision support in primary care". |
| Q35808362 | JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice |
| Q37245464 | Kidney function and estimated vascular risk in patients with primary dyslipidemia |
| Q42658261 | Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study |
| Q38476938 | Management of Coronary Artery Disease in South Asian Populations: Why and How to Prevent and Treat Differently |
| Q36049231 | Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey |
| Q36110461 | Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk |
| Q36012946 | Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models |
| Q36148135 | Missed opportunities for coronary heart disease diagnoses: primary care experience. |
| Q38193335 | Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods |
| Q88495724 | Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam |
| Q34177673 | Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patients |
| Q36368487 | Neighborhood socioeconomic status and coronary heart disease risk prediction in a nationally representative sample |
| Q33781277 | Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome |
| Q36986373 | Patients at high risk for ischemic stroke: identification and actions. |
| Q38168558 | Pre-operative co-morbidity and postoperative survival in the elderly: beyond one lunar orbit |
| Q40047190 | Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors |
| Q34334496 | Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study |
| Q33786492 | Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors |
| Q35187760 | Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, Malaysia |
| Q57416272 | Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: results from a study in British men |
| Q37400825 | Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study |
| Q46740516 | Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women |
| Q35625562 | Predictors of the quality of cardiovascular prevention--a multilevel cross-sectional study |
| Q30248840 | Prevention of stroke: a strategic global imperative |
| Q50326444 | Prevention, management, and rehabilitation of stroke in low- and middle-income countries |
| Q34646503 | Protocol for the 'e-Nudge trial': a randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. |
| Q36161516 | Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts |
| Q42627615 | Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin |
| Q43091078 | Risk factor scoring for coronary heart disease |
| Q39705426 | Risk factors for cardiovascular disease and future osteoarthritis-related arthroplasty: a population-based cohort study in men and women from Malmö, Sweden |
| Q36437820 | Role of noninvasive imaging in asymptomatic high-risk patients |
| Q40565869 | Screening and risk assessment for coronary artery disease in HIV infection: an unmet need |
| Q44235465 | Screening for coronary atherosclerosis with coronary calcium scoring: the "shape" of things to come? |
| Q28740466 | Screening for future cardiovascular disease using age alone compared with multiple risk factors and age |
| Q36905813 | Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors |
| Q82729773 | Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4 |
| Q37136973 | Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care |
| Q47698675 | Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe. |
| Q44509968 | Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort |
| Q36870492 | The Demographic Assessment for Health Literacy (DAHL): a new tool for estimating associations between health literacy and outcomes in national surveys |
| Q33996738 | The Framingham Heart Study's impact on global risk assessment |
| Q43161180 | The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Pr |
| Q51541332 | The Heinz Nixdorf Recall study and its potential impact on the adoption of atherosclerosis imaging in European primary prevention guidelines. |
| Q80148534 | The PARC-AALA trial: carotid artery intima media thickness revisited |
| Q36717062 | The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. |
| Q30876702 | The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor |
| Q44003856 | The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway |
| Q35040566 | The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study |
| Q36190146 | The assessment of endothelial function: from research into clinical practice |
| Q52558315 | The doctor, his patient, and the computerized evidence-based guideline. |
| Q33463873 | The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study |
| Q57152422 | The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril study |
| Q46602672 | The metabolic syndrome and cardiovascular risk in the British Regional Heart Study. |
| Q53592196 | The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES |
| Q33989516 | The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology |
| Q42829839 | The value of risk scores |
| Q34314183 | Update on guidelines for management of hypercholesterolemia |
| Q40955819 | Validation of long-term survival prediction for scheduled abdominal aortic aneurysm repair with an independent calculator using only pre-operative variables |
| Q35640383 | Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study |
| Q34582520 | Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study |
| Q36768750 | Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study |
| Q36547089 | Vegetable intake is associated with lower Frammingham risk scores in Korean men: Korea National Health and Nutrition Survey 2007-2009 |
| Q92949662 | What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention? |
| Q37925640 | What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease? |
| Q36047855 | Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK). |
| Q80399792 | [Calibrating the SCORE cardiovascular risk chart for use in Spain] |
| Q52405117 | [The use of the Framingham-REGICOR equation in a primary care centre. Impact on primary prevention of cardiovascular diseases]. |
Search more.